Robert CC.SmithMD

PubMed

• 814 citations
  Toward a better definition of the restless legs syndrome
  Arthur S. Walters, Michael S. Aldrich, Richard P. Allen, Sonia Ancoli-Israel, David W. Buchholz
  Movement Disorders. 1995-09-01
• 1168 citations
  Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome
  Jun Horiguchi, Magdolna Hornyak, Ulrich Voderholzer, Meir H. Kryger, Robert Skomrow
  Sleep Medicine. 2003-01-01
• 16 citations
  Teaching the medical interview: methods and key learning issues in a faculty development course.
  David S. Hatem, Susan V. Barrett, Mariana G. Hewson, David J.R. Steele, Urip Purwono
  Journal of General Internal Medicine. 2007-10-20

Journal Articles

• Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomiz...  
  Smith RC, Jin H, Li C, Bark N, Shekhar A, Dwivedi S, et al, Schizophr Res, 1/1/2013
• DNA-methylation gene network dysregulation in peripheral blood lymphocytes of schizophrenia patients  
  Auta J, Smith RC, Dong E, Tueting P, Sershen H, Boules S, et al, Schizophr Res, 1/1/2013
• Ziprasidone effects on metabolic makers in patients with diabetes and chronic schizophrenia  
  Lindenmayer JP, Tedeschi F, Yusin Khan A, Kaushik S, Smith RC, Parakadavil M, Clinical Schizophrenia and Related Psychosis, 1/1/2012
• Differential sensory gating functions between smokers and non-smokers among drug-naive first episode schizophrenic patients  
  Chen X, L C, Smith RC, Xiao Z, Wang J, Psychiatry Research, 1/1/2011
• Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients  
  Greenbaum,L,. Smith RC, Lorberboym M, Alkelai A,, Zozulinsky P, LifshytzT , Kohn Y, Djaldetti R, Lerer B, Psychopharmacology, 1/1/2011
• Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers  
  Smith, R. C., Zhubi A., Sershen H., Lajtha A., Davis J. M., Costa E., Guidotti A., Schizophrenia Research, 1/1/2010
• Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized five month study  
  Smith, R., Lindenmayer J.-P., Hu Q., Kelly E., Viviano T., Cornwell J., Vaidhyanathaswamy S., Marcovina S., Davis J, Schizophrenia Research, 1/1/2010
• Further evidence for association of RSG2 gene with antipsychotic-induced Parkinsonism; protective role of a functional polymorphism in the 3’-untranslated region  
  Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K, Korner M, Lancet D, Ben-Asher E, Lerer B, Pharmacogenomics, 1/1/2009
• Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder  
  Smith, RC. Lindenmayer, JP, Davis JM, Cornwell J, Noth, K, Sershen H, Lajtha A, Schizophrenia Research, 1/1/2009
• Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomi...  
  Smith RC, Lindenmayer JP, Davis JM, Kelly E, Viviano TF, Cornwell J, Hu Q, Khan A, Vaidhyanathaswamy S, J. Clinical Psychiatry, 1/1/2009
• An upregulation of DNA-methyltransferase 1 and 3a expressed in telencephalic GABAergic neurons of schizophrenia patients is also detected in peripheral blood lymphocytes  
  Zhubi A., Veldic M., Puri N.V. , Kadriu B., Caruncho H., Loza I. Sershen H., Lajtha A., Smith RC, Guidotti A., Davis JN, Costa E, Schizophrenia Research, 1/1/2009
• Allelic Variation in ApoC3, ApoA5 and LPL Genes and 1st and 2nd Generation Antipsychotic Effects on Serum Lipids in Patients With Schizophrenia  
  Smith RC, Segman RH, Golcer-Dubner G, Pavlov V, Lerer B, Pharmacogenomics, 1/1/2008
• Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia  
  Smith RC, Warner- Cohen J, Melissa M, Butler E , Kelly E, Khan A, Neuropsychopharmacology, 1/1/2006
• Clozapine, Risperidone, Olanzapine, and Conventional Antipsychotic Drug Effects on Glucose, Lipids, and Leptin in Schizophrenic Patients  
  Smith, RC, Lindenmayer J-P, Bark N,Warner-Cohen J, Vaidhyanathaswamy S, Khandat A, Int. J. Neuropsychopharmacology, 1/1/2005
• Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia  
  Smith RC, Singh, A, Infante M, Khandat A, Kloos, A, Neuropsychopharmacology, 1/1/2002
• Effects of cigarette smoking on psychopathology scores in schizophrenic patients: An experimental study  
  Smith RC, Infante M, Ali A, Nigam S, Substance Abuse, 1/1/2001
• Hyperglycemia in schizophrenic patients treated with olanzapine  
  Lindenmayer JP, Smith RC, Singh A, Parker B, Chou E, Kotsaftis, A, J. Clinical Psychopharmacology, 1/1/2001
• Olanzapine’s effects on neurocognitive functioning in medication refractory schizophrenia  
  Smith RC, Infante M, Singh A, Khandat A, Int. J. Neuropsychopharmacology, 1/1/2001
• Hyperglycemia associated with the use of atypical antipsychotics  
  Lindenmayer, JP, Nathan A-M, Smith RC, J. Clin. Psychiatry, 1/1/2001
• Stability of neurological soft signs in chronically hospitalized schizophrenic patients  
  Smith RC, Hussian MI, Chowdhury SA, Stearns A, J. Neuropsychiatry Clin. Neurosciences, 1/1/1999
• Nonresponding schizophrenia; Differentiation by neurological signs and neuropsychological tests  
  Smith RC, Kadewari RP, Rosenberger JR, Bhattacharyya A, Schizophrenia Bulletin, 1/1/1999
• Clinical and neurocognitive effects of clozapine and risperidone in treatment refractory schizophrenics: A prospective study  
  Lindenmayer JP, Iskander A, Park M, Fotini-Sponia A, Czobor P, Smith R, Allen D, J. Clinical Psychiatry, 1/1/1998
• Neurological soft signs and response to risperidone in chronic schizophrenia  
  Smith, RC, Kadewari, RP, Biological Psychiatry, 1/1/1996
• Efficacy of risperidone in reducing positive and negative symptoms in medication refractory schizophrenia: An open prospective study  
  Smith, RC, Chua, JW, Lipetsker, B, Bhattacharyya, A, J. Clinical Psychiatry, 1/1/1996
• Lower dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients  
  Smith, R.C., Arch Gen. Psychiatry, 1/1/1994
• Join now to see all

Books/Book Chapters

• Tardive Dyskinesia: Biological Mechanisms and Clinical Aspects 
  Chapter: Is the dopaminergic supersensitivity of tardive dyskinesia valid 
  Page 3 - 21Smith, R.C.Editors: Wolf, M..American Psychiatric Press, Inc., Washington, D.C.1988
• The Chronically Mentally Ill: Research and Services 
  Chapter: Neuroleptic blood level monitoring in maintenance studies of schizophrenic outpatients 
  Page 143 - 158Sajadi, C., Smith, R.C., Shvartsburd, A., Morton, V., Gordon, J., Mirabi, MEditors: M. Mirabi.Spectrum Books, New York, NY1984
• Brain Neurotransmitter and Receptors in Aging and Age-Related Disorders 
  Chapter: The effect of age and chronic neuroleptic drug treatment on cell populations in the neostriatum of Fisher 344 rats 
  Page 59 - 80Brizzee, R.K., Samorajski, T., Smith, R.C., Brizzee, D.L.Raven Press1981
• Brain Neurotransmitter and Receptors in Aging and Age Related Disorders 
  Chapter: Aging, receptors and neuroleptic drugs 
  Page 231 - 243Smith, R.C., Shelat, H.S., Sammeta, J., Misra, C.H.Raven Press1981
• Brain Neurotransmitter and Receptors in Aging and Age Related Disorders 
  Chapter: Cholinergic drugs and memory disorders in Alzheimer's-type Dementia 
  Page 245 - 254Vroulis, G.A., Smith, R.C.Raven Press1981
• PCP Historical Current Perspectives 
  Chapter: Acute versus chronic administration of phencyclidine: Effects on behavior and brain biochemistry 
  Page 243 - 291Smith, R.C., Leelavathi, D.E., Hsu, L., Ho, B.T., Tansey, W., Taylor, D., Biggs, C.Editors: Domino, E.F..NPP Books, Ann Arbor, MI1981
• Neuroreceptors: Basic and Clinical Aspects 
  Chapter: Receptor studies of the effects and blood levels of neuroleptic and antidepressant drugs 
  Page 215 - 229Smith, R.C., Misra, C.H., Leelavathi, D.E., Shelat, H., Allen, R., Schoolar, J., Gordon, J.Editors: Usdin, E., Bunney, W.E., Davis, JM.John Wiley & Sons, New York & England1981
• Tardive Dyskinesia: Research and Treatment 
  Chapter: Effects of cholinergic drugs on the involuntary movements of tardive dyskinesia 
  Page 411 - 418Tamminga, C., Smith, R.C., Davis, JMEditors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Psychopharmacology of Aging 
  Chapter: Aging and the behavioral effects of dopamine agonists in rodents. 
  Page 135 - 143Smith, R.C., Strong, J.R., Strong, JEditors: Fann, WE.Spectrum Books, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: The prevalence of tardive dyskinesia 
  Page 269 - 279Crane, G., Smith, R.C.Editors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: Maintenance antipsychotic therapy and the risks of tardive dyskinesia 
  Page 511 - 522Chan, C.H., Davis, JM, Smith, R.C., Reed, K.Editors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: Neuroendocrine effects of dopamine agonists in patients with tardive dyskinesia 
  Page 345 - 354Tamminga, C., Smith, R.C., Pandey, G., Frohman, L., Davis, JMEditors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: Behavioral effects of apomorphine and amphetamine in tardive dyskinesia patients 
  Page 333 - 345Smith, R.C., Tamminga, C., Davis, J.Editors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: History of neuroleptic drugs and tardive dyskinesia 
  Page 309 - 314Smith, R.C., Klass, N.D., Tritici, M.Editors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• Tardive Dyskinesia: Research and Treatment 
  Chapter: Behavioral and biochemical studies of the effects of chronic neuroleptic drugs: Interaction with age 
  Page 65 - 88Smith, R.C., Leelavathi, D.E.Editors: Smith, R.C., Fann, W.E., Davis, JM., Domino, E.F..Spectrum Press, New York, NY1980
• The Interface Between Psychodynamic and Behavioral Therapies 
  Chapter: Concurrent psychotherapy and behavior therapy: Treatment of Psychoneurotic outpatients 
  Page 257 - 274Seagraves, R.T., Smith, R.C.Editors: Marmor, J., Woods, S.M..Plenum1980
• Tardive Dyskinesia: Research and Treatment 
  Fann, W.E., Smith, R.C., Davis, JM, Domino, E.Spectrum Press, New York, NY1980
• Catecholamine: Basic Clinical Frontiers 
  Chapter: Effects of age and chronic neuroleptics on measures of supersensitivity 
  Page 842 - 844Smith, R.C., Misra, C.H., Ho, B.T., Tansey, L.W.Editors: Usdin, E., Koplin, I.J., Barchas, J.Pergamon Press, New York, NY1979
• The Kinetics of Psychiatric Drugs 
  Chapter: Blood levels of neuroleptic drugs, clinical response, and plasma prolactin in chronic non-responding schizophrenic patients 
  Page 137 - 170Smith, R.C., Crayton, J.W., Tamminga, C., Dekirmenjian, H., Schoolar, R.C., Davis, JMEditors: Schoolar, J.C., Claghorn, JL.Brunner/Mazel, New York, NY1979
• Cholinergic Mechanisms and Psychopharmacology 
  Chapter: Cholinergic mechanisms in schizophrenia, mania and depression 
  Davis, JM Janowsky, D., Tamminga, C.T., Smith, R.C.Editors: D. Jendon.Plenum, New York, NY1977
• Pharmacokinetics, Psychoactive Drug Blood Levels and Clinical Response 
  Chapter: Blood level, mood, and MHPG responses to diazepam in man 
  Page 141 - 156Smith, R.C., et alEditors: Gottschalk, L., and Merlis, S..Spectrum Books, New York, NY1976
• Join now to see all

Abstracts/Posters

• Relative potencies of amphetamine and methylphenidate on mood and activation in man and stereotyped behavior and locomotor activity in rats
  Smith, R.C., Davis, JM, Schlemmer, F., Abst. Soc. for Neurosci. 4th Annual Meeting, 1/1/1974

Other

• Patient-centered interviewing 
  Smith RC, Fortin AH, Dwamena FC
  http://www.uptodate.com/contents/patient-centered-interviewing
  UpToDate, Wolters Kluwer Health - 2013-01-02
• Primary care management of medically unexplained symptoms 
  Smith RC, Dwamena FC
  http://www.uptodate.com/contents/primary-care-management-of-medically-unexplained-symptoms
  UpToDate, Wolters Kluwer Health - 2012-12-06
• The difficult patient encounter 
  Smith RC, Fortin AH, Dwamena FC
  http://www.uptodate.com/contents/the-difficult-patient-encounter
  UpToDate, Wolters Kluwer Health - 2012-02-16